- Home
- ECVT vs SYRE Comparison
ECVT vs SYRE Comparison
Compare ECVT & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECVT
- SYRE
- Stock Information
- Founded
- ECVT 1935
- SYRE 2013
- Country
- ECVT United States
- SYRE United States
- Employees
- ECVT N/A
- SYRE N/A
- Industry
- ECVT Major Chemicals
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- ECVT Industrials
- SYRE Health Care
- Exchange
- ECVT Nasdaq
- SYRE Nasdaq
- Market Cap
- ECVT 1.0B
- SYRE 1.1B
- IPO Year
- ECVT 2017
- SYRE 2016
- Fundamental
- Price
- ECVT $9.05
- SYRE $15.78
- Analyst Decision
- ECVT Strong Buy
- SYRE Buy
- Analyst Count
- ECVT 3
- SYRE 5
- Target Price
- ECVT $10.00
- SYRE $55.00
- AVG Volume (30 Days)
- ECVT 1.3M
- SYRE 414.7K
- Earning Date
- ECVT 10-30-2025
- SYRE 11-06-2025
- Dividend Yield
- ECVT N/A
- SYRE N/A
- EPS Growth
- ECVT N/A
- SYRE N/A
- EPS
- ECVT N/A
- SYRE N/A
- Revenue
- ECVT $723,462,000.00
- SYRE N/A
- Revenue This Year
- ECVT $16.62
- SYRE N/A
- Revenue Next Year
- ECVT $6.11
- SYRE N/A
- P/E Ratio
- ECVT N/A
- SYRE N/A
- Revenue Growth
- ECVT 4.93
- SYRE N/A
- 52 Week Low
- ECVT $5.24
- SYRE $10.91
- 52 Week High
- ECVT $9.69
- SYRE $40.26
- Technical
- Relative Strength Index (RSI)
- ECVT 53.21
- SYRE 41.72
- Support Level
- ECVT $8.90
- SYRE $15.80
- Resistance Level
- ECVT $9.69
- SYRE $17.58
- Average True Range (ATR)
- ECVT 0.24
- SYRE 0.74
- MACD
- ECVT -0.01
- SYRE -0.12
- Stochastic Oscillator
- ECVT 27.53
- SYRE 1.90
About ECVT Ecovyst Inc.
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has two reporting segments: Ecoservices and Advanced Materials & Catalysts. Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications. Maximum revenue is generated from Ecoservices segment.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.